Wordt geladen...
Latest progress in tyrosine kinase inhibitors
Here we discuss the latest progress in development of some kinase inhibitors such as inhibitors of c-MET, LIM and Bcr-Abl kinases. Importantly, many oncogenic kinases signal via the mTOR pathway, suggesting a common target for drug combinations.
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4012733/ https://ncbi.nlm.nih.gov/pubmed/24727648 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|